A company called MedBright AI Investments Inc. is telling people that they are being asked some questions by a group called OTC Markets about some newsletters and emails talking about the company and its products. They want to make sure everyone knows what's going on and that they are not doing anything wrong. MedBright AI Investments Inc. helps other companies in the healthcare technology field with their money and business plans, trying to make good investments for everyone who owns a part of the company. Read from source...
- The company has been requested by OTC Markets Group Inc. to issue a statement about promotional activity concerning its common shares traded on the OTCQB market (operated by OTC Markets). This is a serious allegation that implies the company may have engaged in illegal or unethical practices to inflate its stock price and attract more investors.
- The article does not provide any evidence or details about the nature of the promotional activities, who was involved, when and where they occurred, or what consequences the company might face if found guilty. This leaves readers with many questions and doubts about the credibility and reliability of the information presented in the article.
- The article mentions that Kevin Vander, a self-proclaimed healthcare analyst, published three promotional newsletter emails discussing the Company, its technologies and the healthcare services market. However, it does not explain how these emails are related to the company or why they would trigger an investigation by OTC Markets. It also does not disclose any potential conflicts of interest between Kevin Vander and the company or its management. For example, does he own any shares of the company? Does he receive any compensation or benefits for promoting the company? Has he ever been involved in any previous controversies or scandals involving other healthcare companies?
- The article then proceeds to describe the services provided by Longtable, a digital marketing agency that has been hired by the company to assist with its investor relations and public relations strategies. However, it does not explain how this relationship would affect the company's reputation or compliance with OTC Markets rules and regulations. It also does not provide any information about Longtable's track record, qualifications, experience, or fees. Moreover, it states that neither Longtable nor any of its principals currently own any interest in the company, which contradicts the previous statement that they have been hired to help with investor relations and public relations.
- The article ends with a brief introduction of MedBright AI Investments Inc., its mission, vision, and values. However, it does not mention how these principles align with or differ from those of the company's portfolio companies or potential investment opportunities. It also does not provide any examples of successful or failed investments made by the company in the past or present. Furthermore, it does not address how the company plans to mitigate the risks and challenges associated with its promotional activities and OTC Markets investigation, or how it intends to communicate with its shareholders and stakeholders about these issues.